Simpirica Spine closes $22M in funding for the LimiFlex stabilization device

 
 
 
Simpirica Spine website
Simpirica Spine Closes $22 Million Series C Funding Led by Norwest Venture Partners (press release)

Simpirica Spine, Inc., developer of minimally invasive, flexion-restricting stabilization devices for the spine, today announced the closing of a $22 million Series C round of venture funding, led by new investor Norwest Venture Partners (NVP). Existing investors De Novo Ventures and U.S. Venture Partners (USVP) also participated in this round, which will be used to support the European commercialization of the company’s lead product, the Lim...